Loading...

Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer

This study identified LIMK2 kinase as a disease-specific target in castration resistant prostate cancer (CRPC) pathogenesis, which is upregulated in response to androgen deprivation therapy, the current standard of treatment for prostate cancer. Surgical castration increases LIMK2 expression in mous...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Lett
Main Authors: Nikhil, Kumar, Chang, Lei, Viccaro, Keith, Jacobsen, Max, McGuire, Callista, Satapathy, Shakti R., Tandiary, Michael, Broman, Meaghan M., Cresswell, Gregory, He, Yizhou J., Sandusky, George E., Ratliff, Timothy L., Chowdhury, Dipanjan, Shah, Kavita
Format: Artigo
Sprog:Inglês
Udgivet: 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7079209/
https://ncbi.nlm.nih.gov/pubmed/30716360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2019.01.035
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!